FDA to review Capricor's DMD therapy at July advisory meeting

June 26, 2026 10:02 AM

Capricor Therapeutics (NASDAQ: CAPR) announced that the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) is scheduled to meet ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found